Bendroflumethiazide

Država: Novi Zeland

Jezik: engleski

Izvor: Medsafe (Medicines Safety Authority)

Aktivni sastojci:

Bendroflumethiazide 2.5mg;  ;  

Dostupno od:

Ipca Pharma (NZ) Pty Limited

INN (International ime):

Bendroflumethiazide 2.5 mg

Doziranje:

2.5 mg

Farmaceutski oblik:

Tablet

Sastav:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

Jedinice u paketu:

Blister pack, PVC/PVDC, 14 tablets

Razred:

Prescription

Tip recepta:

Prescription

Proizveden od:

Ipca Laboratories Limited

Terapijske indikacije:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Proizvod sažetak:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

Datum autorizacije:

2006-06-28